122 related articles for article (PubMed ID: 22503459)
1. [Automated screening for transfusionnal hemochromatosis].
Costello R; Huret G; Sappa E; Bergoin-Costello V
Transfus Clin Biol; 2012 Apr; 19(2):57-9. PubMed ID: 22503459
[TBL] [Abstract][Full Text] [Related]
2. Adverse transfusion reactions in patients with aplastic anaemia or myelodysplastic syndromes.
Moncharmont P; Quittançon E; Barday G; Benamara A;
Vox Sang; 2019 May; 114(4):349-354. PubMed ID: 30818416
[TBL] [Abstract][Full Text] [Related]
3. [Hemochromatosis after chemotherapy. Is there a treatment recommendation?].
Link H
MMW Fortschr Med; 2011 Jun; 153(22):24. PubMed ID: 21688405
[No Abstract] [Full Text] [Related]
4. Red Blood Cell Transfusion Dependency and Hyperferritinemia Are Associated with Impaired Survival in Patients Diagnosed with Myelodysplastic Syndromes: Results from the First Polish MDS-PALG Registry.
Waszczuk-Gajda A; Mądry K; Machowicz R; Drozd-Sokołowska J; Stella-Hołowiecka B; Mital A; Obara A; Szmigielska-Kapłon A; Sikorska A; Subocz E; Jędrzejczak WW; Dwilewicz-Trojaczek J
Adv Clin Exp Med; 2016; 25(4):633-41. PubMed ID: 27629836
[TBL] [Abstract][Full Text] [Related]
5. Screening for iron overload and HFE mutations in a university hospital.
Remacha AF; Carrasco M; Sardà MP; Barceló MJ; Blesa I; Baiget M
Haematologica; 2000 Aug; 85(8):873-4. PubMed ID: 10942939
[No Abstract] [Full Text] [Related]
6. [Secondary hemochromatosis in polytransfused patients with myelodysplastic syndromes].
Jaeger M; Aul C; Söhngen D; Germing U; Schneider W
Beitr Infusionsther; 1992; 30():464-8. PubMed ID: 1284762
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of transfusion hemochromatosis].
Aul C; Gattermann N; Jaeger M
Internist (Berl); 1997 Sep; 38(9):865-6. PubMed ID: 9410837
[No Abstract] [Full Text] [Related]
8. Adverse impact of hyperferritinemia and transfusion dependency on treatment success in myelodysplastic syndrome.
Cakar MK; Yegin ZA; Baysal NA; Altındal S; Pamukçuoğlu M; Celik B; Yenicesu I
Transfus Apher Sci; 2013 Jun; 48(3):397-401. PubMed ID: 23619324
[TBL] [Abstract][Full Text] [Related]
9. Transfusional hemochromatosis: quantitative relation of MR imaging pituitary signal intensity reduction to hypogonadotropic hypogonadism.
Sparacia G; Iaia A; Banco A; D'Angelo P; Lagalla R
Radiology; 2000 Jun; 215(3):818-23. PubMed ID: 10831704
[TBL] [Abstract][Full Text] [Related]
10. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
Sanz C; Nomdedeu M; Belkaid M; Martinez I; Nomdedeu B; Pereira A
Transfusion; 2013 Apr; 53(4):710-5. PubMed ID: 22845746
[TBL] [Abstract][Full Text] [Related]
11. The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes.
Platzbecker U; Hofbauer LC; Ehninger G; Hölig K
Leuk Res; 2012 May; 36(5):525-36. PubMed ID: 22300879
[TBL] [Abstract][Full Text] [Related]
12. Secondary hemochromatosis as a long-term complication of the treatment of hematologic malignancies.
Lichtman SM; Attivissimo L; Goldman IS; Schuster MW; Buchbinder A
Am J Hematol; 1999 Aug; 61(4):262-4. PubMed ID: 10440913
[TBL] [Abstract][Full Text] [Related]
13. Consensus statement on iron overload in myelodysplastic syndromes.
Bennett JM;
Am J Hematol; 2008 Nov; 83(11):858-61. PubMed ID: 18767130
[TBL] [Abstract][Full Text] [Related]
14. Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial).
Angelucci E; Santini V; Di Tucci AA; Quaresmini G; Finelli C; Volpe A; Quarta G; Rivellini F; Sanpaolo G; Cilloni D; Salvi F; Caocci G; Molteni A; Vallisa D; Voso MT; Fenu S; Borin L; Latte G; Alimena G; Storti S; Piciocchi A; Fazi P; Vignetti M; Tura S
Eur J Haematol; 2014 Jun; 92(6):527-36. PubMed ID: 24580147
[TBL] [Abstract][Full Text] [Related]
15. [Guidelines for diagnosis and treatment of secondary iron overload in patients with congenital anemia].
Cario H; Grosse R; Janssen G; Jarisch A; Meerpohl J; Strauss G;
Klin Padiatr; 2010 Nov; 222(6):399-406. PubMed ID: 20862634
[TBL] [Abstract][Full Text] [Related]
16. [Blood transfusion and monitoring. Post-transfusion hemochromatosis].
Bastion Y
Soins; 1996 Apr; (605):27-8. PubMed ID: 8716246
[No Abstract] [Full Text] [Related]
17. [Hemochromatosis: the importance of mutation screening in the family].
ter Braak N; Erdkamp FL; van Deursen CT
Ned Tijdschr Geneeskd; 2009 Apr; 153(16):765-7. PubMed ID: 19469149
[No Abstract] [Full Text] [Related]
18. [Effective treatment of anaemia with darbepoetin alfa in a patient with hereditary hemochromatosis].
Jahnke K; Korfel A; Thiel E
Dtsch Med Wochenschr; 2004 Apr; 129(14):739-40. PubMed ID: 15042489
[No Abstract] [Full Text] [Related]
19. [Hereditary hemochromatosis and mild unconjugated hyperbilirubinemia in patient with ulcerative colitis].
Dynowski W; Zwolińska-Wcisło M; Mach T
Przegl Lek; 2012; 69(11):1232-4. PubMed ID: 23646454
[TBL] [Abstract][Full Text] [Related]
20. Natural history of hemochromatosis: heading down the up escalator?
Adams PC
Gastroenterology; 2008 Dec; 135(6):1855-7. PubMed ID: 19000683
[No Abstract] [Full Text] [Related]
[Next] [New Search]
